A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more.

Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency (DOGE), is doubling down on his support for expanding access to affordable GLP-1 weight-loss medications like Ozempic.